“ An Orally Active Formulation of Angiotensin-(1-7) Produces an Antithrombotic Effect ”. Clinics 66, no. 5 (January 1, 2011): 837–841. Accessed June 18, 2024. https://revistas.usp.br/clinics/article/view/19562.